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ABSTRACT Proteins must be stable to accomplish their biological function and to avoid enzymatic degradation. Consti-
tutive proteolysis, however, is the main source of free amino acids used for de novo protein synthesis. In this paper the
delicate balance of protein stability and degradability is discussed in the context of function of major histocompatibility
complex (MHC) encoded protein. Classical MHC proteins are single-use peptide transporters that carry proteolytic degra-
dation products to the cell surface for presenting them to T cells. These proteins fulfill their function as long as they bind their
dissociable ligand, the peptide. Ligand-free MHC molecules on the cell surface are practically useless for their primary
biological function, but may acquire novel activity or become an important source of amino acids when they lose their
compact stable structure, which resists proteolytic attacks. We show in this paper that one or more of the stabilization centers
responsible for the stability of MHC-peptide complexes is composed of residues of both the protein and the peptide, therefore
missing in the ligand-free protein. This arrangement of stabilization centers provides a simple means of regulation; it makes
the useful form of the protein stable, whereas the useless form of the same protein is unstable and therefore degradable.
INTRODUCTION
Proteins must be stable to ensure their biological activity.
However, protein stability must be limited, since degrada-
tion products of useless or inactive proteins are the main
source of amino acid for de novo protein synthesis. A simple
means of regulation, which makes a useful form of a protein
stable and the useless form unstable, will be presented. It
derives from the study of stabilization centers in an immuno-
logically relevant peptide receptor and transporter.
Cell surface glycoproteins, encoded by genes of the major
histocompatibility complex (MHC), begin and end their
lifetime as empty molecules. At the cell surface however
they are complexed with peptide ligands that are generated
within the cell by limited proteolytic degradation and loaded
intracellularly (reviewed in Germain and Margulies, 1993;
Maenaka and Jones, 1999). A single MHC molecule can
bind various, but not all, kinds of peptides (Rammensee,
1995; Rammensee et al., 1995). Peptide loading of MHC
class I and class II molecules via the classical antigen
presentation pathways occurs in distinct cellular compart-
ments where various peptides compete for the available
binding sites (reviewed in Harding and Geuze, 1993; Raj-
navo¨lgyi, 1994). The resulting complexes are then trans-
ported to the cell surface and presented to T cells (Garcia
and Teyton, 1998). The interaction between newly synthe-
sized MHC class I and class II molecules and their ligands
is assisted by various chaperones, which support the pep-
tide-accessible conformation of the molecule (Koopmann et
al., 1997; Busch et al., 2000). Ligand-free MHC proteins
usually do not reach the cell surface, since they are degraded
rapidly inside the cell. MHC-peptide complexes expressed
on the cell surface, however, are stable for several hours or
even for days (Lanzavecchia et al., 1992; Hansen et al.,
2000). Peptide ligands bind noncovalently to MHC mole-
cules. Therefore, they dissociate from the heterodimers at a
rate determined by the strength of interactions between the
two molecules.
As a rule, ligand-free MHC molecules that happen to
reach the cell surface are also degraded quickly, and only a
few survive, either by reloading their ligand binding site
with peptides present in the extracellular environment or by
internalization in intact form into peptide-rich endosomes.
Fluorescence measurements suggested the presence of a few
percent of unliganded and still compact MHC I molecules
on the cell surface (Matko et al., 1994; Edidin et al., 1997).
Under in vitro conditions, ligand-free MHC class I proteins
were demonstrated to exhibit a molten globule state, which
resembled what was known as an intermediate in the dena-
turation process (Bouvier and Wiley, 1998). A molten glob-
ule is much less compact than a native protein; therefore, it
is more sensitive to proteolytic attacks and it may interact
differently with other proteins such as chaperones. Ligand-
free MHC class II molecules are found on the surface of
professional antigen-presenting cells, such as immature
dendritic cells and B cells in association with chaperones
(Santambrogio et al., 1999; Arndt et al., 2000).
The overall structures of the peptide-binding domains of
MHC class I and class II molecules are rather similar. They
are built up of a large eight-stranded -sheet with two
mostly -helical regions on top of the -sheets. The MHC
class I helices are formed by the 150-155 and 158-184
residues on one side of the peptide binding groove and by
the 2138-2148 and 2151-2180 amino acids on the other
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side. In MHC class II molecules, two long helices, 54-76
and 52-90, border the two sides of the ligand binding site
(Brown et al., 1993; Stern et al., 1994; Madden, 1995). The
major difference between the detailed structures of the
ligand-binding sites is that they are closed by conserved
amino acids at both the N- and C-termini in class I mole-
cules (Madden et al., 1991), whereas they are open at both
ends in class II molecules (Brown et al., 1993). Therefore,
MHC class I molecules bind peptides of 8 to 10 residues in
length, whereas MHC class II molecules can adopt much
longer peptides that extend the binding groove (Ram-
mensee, 1995; Rammensee et al., 1995; Rajnavo¨lgyi et al.,
1997; Gogola´k et al., 2000).
Stabilization centers (SCs), defined as certain clusters of
residues involved in cooperative long-range interactions,
were described as being primarily responsible for keeping
the three-dimensional structure of a protein intact (Doszta´-
nyi et al., 1997). Residues involved in SCs, i.e., elements of
SCs, are defined by considering the contact maps of proteins
of known structure. Residues are considered to be in contact
if at least one of their heavy atom distances is less than the
sum of the van der Waals radii of the two atoms plus 1.0 Å.
Two residues are considered to be in long-range contact if
they are at least 10 residues apart in the amino acid se-
quence or if they belong to separate polypeptide chains of
the protein. To identify SC elements, we looked for sup-
porting residues from the flanking tetrapeptides on both
sides of the two residues that are involved in long-range
interactions. There are 44  256 ways to select these two
pairs of supporting residues. One central residue and its two
selected supporting residues (one on each side) are together
called a residue triplet. If there is at least one of the 256
cases in which the two triplets form at least seven interresi-
due interactions (out of the nine theoretically possible), the
central residues of both triplets are considered to be SC
elements (Doszta´nyi et al., 1997). Properties of SCs are
discussed in more detail elsewhere (Doszta´nyi et al., 1997;
Doszta´nyi and Simon, 1999), and a public server is avail-
able at http://www.enzim.hu/scpred/scpred.html to identify
SC elements of a given protein of known structure and to
predict such elements when only the amino acid sequence of
the protein is available.
According to our earlier study on a 600-member repre-
sentative set of unrelated proteins of the Protein Data Bank
(PDB), SCs were found in all proteins, and almost 25% of
the residues were estimated to be SC elements. This per-
centage was rather variable in proteins that belonged to
different secondary structure subclasses. For example, in
all- proteins SCs were abundant, whereas in the all-
subclass they were rather rare. This suggested that the
stability of a certain structure requires a certain number of
SC elements. Comparison of proteins of the same function
in thermophilic microorganisms and in mammals showed
that as few as one or two additional SC elements in a protein
results in a denaturation temperature that is higher by 30–
50°C. Apparently, protein stability can be adjusted signifi-
cantly by introducing or removing a few SC elements
(Doszta´nyi, Z., Szirtes, G., Magyar, Cs., Simon, I., manu-
script in preparation).
In this work, the stabilization centers of peptide-com-
plexed MHC class I and class II proteins were analyzed. Our
studies revealed that residues of the bound peptide could be
involved in SCs and thus may contribute to stability of the
MHC molecule.
TABLE 1 MHC I-peptide complexes
No. PDB code MHC I allotype Origin of peptide Reference
1 1hhg HLA-A*0201 HIV-1 gp120 (197–205) Madden et al., 1993
2 1hhh HLA-A*0201 Hep BV capsid (18–27) as above
3 1hhi HLA-A*0201 Flu-matrix (58–66) as above
4 1hhj HLA-A*0201 HIV-1 RT (476–484) as above
5 1hhk HLA-A*0201 HTLV-Tax as above
6 2clr HLA-A*0201 Calreticulin Collins et al., 1994
7 1b0g HLA-A*0201 HLA-A2 specific human peptide “P1049” Zhao et al., 1999
8 1agd HLA-B*0801 HIV-1 gag (24–31) Reid et al., 1996
9 1aln HLA-B*3501 HIV-1 Nef (74–81) Smith et al., 1996a
10 1a9e HLA-B*3501 EBNA3C derivative Menssen et al., 1999
11 1alo HLA-B*5301 P-falciparum liver antigen (1786–94) Smith et al., 1996b
12 1alm HLA-B*5301 HIV-2gag (182–190) as above
13 1hoc H-2Db Flu A Np (366–374) Young et al., 1994
14 1ce6 H-2Db SV Np (324–332) Glithero et al., 1999
15 1bz9 H-2Db Synthetic peptide “P1027” Zhao et al., 1999
16 2vaa H-2Kb VSV Np (52–59) Fremont et al., 1992
17 2vab H-2Kb SV Np (324–332) as above
18 1vac H-2Kb Chicken OVA (258–265) Fremont et al., 1995
19 1vad H-2Kb -glucosidase (438–46) as above
20 1ld9 H-2Ld Endogenous peptide p29 Balendiran et al., 1997
21 1ddh H-2Dd HIV-1 gp160 V3 loop (P18–I10) Li et al., 1998
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DATABASE
Peptide binding domains of eight MHC class I and seven MHC class II
proteins, complexed with one or several peptides, were studied. The PDB
codes, the MHC allotype, and the origin of the bound peptides are listed in
Tables 1 and 2.
RESULTS AND DISCUSSION
Stabilization centers that contain an SC element, located in
the helices that form the sides of the peptide binding
grooves, in all of the 31 complexes are listed in Tables 3–6.
Representative examples, shown in Fig. 1, include the MHC
class I molecules HLA-B*5301 complexed with the HIV-2
gag (182–190) peptide and HLA-B*0801 complexed with
the HIV-1 gag (24–31) peptide, as well as the MHC class II
molecule HLA-DR1 (composed of HLA-A*0101, HLA-
B1*0101) complexed with the human influenza A virus
hemagglutinin 306–318 peptide.
Fig. 1 clearly demonstrates that the eight-stranded
-sheets are stabilized by a large number of SCs; an average
of 27 residues are involved in these interactions. On the
other hand, the number of SCs connecting the helices to the
eight-stranded -sheet plateau is rather limited; these SC
element pairs are listed in Tables 3 and 4. There are only a
few cases where both helices are linked to the -sheet by
SCs. This finding is in good agreement with our previous
results obtained on a large data set (Doszta´nyi and Si-
mon, 1999), which indicated that in the / subclass of
proteins, which include the MHC proteins, 46.5% of the
SC elements connect one extended chain to another,
whereas only 1.5% of the SC elements connect an ex-
tended chain to a helix.
TABLE 2 MHC II-peptide complexes
No. PDB code MHC II allotype Origin of peptide Reference
1 1dlh HLA-DR1 (DRA*0101, DRB1*0101) Flu HA (306–318) Stern et al., 1994
2 1aqd HLA-DR1 (DRA*0101, DRB1*0101) Endogenous peptide A2 (104–117) Murthy and Stern, 1997
3 2seb HLA-DR4 (DRA*0101, DRB1*0401) Human Collagen II (1168–1179) Dessen et al., 1997
4 1bx2 HLA-DR2 (DRA*0101, DRB1*1501) Human Myelin Basic Protein (85–98) Smith et al., 1998
5 1a6a HLA-DR3 (DRA*0101, DRB1*0301) CLIP (87–101) Ghosh et al., 1995
6 1iea H-2Ek Murine hemoglobin (64–76) Fremont et al., 1996
7 1ieb H-2Ek Murine hsp 70 (236–248) as above
8 1iao H-2Ad OVA (323–334)  signal residues Scott et al., 1998
9 2iad H-2Ad Flu HA (126–138)  signal residue as above
10 1iak H-2Ak Lysosyme HEL (50–62) Fremont et al., 1998
TABLE 3 Intramolecular stabilization center elements of MHC class I molecules
PDB code MHC I allotype
Stabilization center elements
2157
† 2168
† 2169
† 2170
† 2171
† 2140
†
1hhg HLA-A*0201 2130 2103
1hhh 2130 2103
1hhi 2130 2103 2107
1hhj 2130 2103
1hhk 2130
2clr 2130 2103 2107 155
†
1b0g 2130 2103
1agd HLA-B*0801 2130 155
†
1aln HLA-B*3501 2130
1a9e 2103 2107
1alo HLA-B*5301 2103 2107 155
†
1alm 2130 2103 155
†
1hoc H-2Db 2130
1ce6 130 2103 2103,107 155
†
1bz9 2130 155,59
† 155
†
2vaa H-2Kb 155
†
2vab 2130 155
†
1vac 2130 155
† 2123
1vad 155
†
1ld9 H-2Ld
1ddh H-2Dd 2103
Stabilization centers involving at least one residue from helices are documented.
†Residues of helical origin.
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At least one residue of the bound peptide is involved in a
SC in every one of the class II protein-peptide complexes
analyzed, and also in most of the class I protein-peptide
complexes studied (see Tables 5 and 6). In all these cases
the complementary residues of the SC elements in the
bound peptides were localized in the helices of the MHC
molecule and never in the -sheet. Because the accommo-
dated peptides adopt an extended conformation in the MHC
class I groove (Madden et al., 1991) and a polyproline
II-like conformation in the MHC II groove (Jardetzky et al.,
1996), the relatively large number of these helix-extended
chain-associated SC connections suggests significant bio-
logical functions of these connections. Let us consider the
two MHC classes separately.
Stabilization centers of MHC class II-peptide
complexes
In MHC class II molecules, some of the SC elements of the
peptides are identical to the so-called anchor residues, such
as those located in relative positions 1 and 9 of the core
sequence. These are characterized as strongly interacting
peptide residues. When the anchors were not SC elements
TABLE 4 Intramolecular stabilization center elements of MHC class II molecules
PDB code MHC II allotype
Stabilization center elements
59† 63† 66† 76† 80†
1dlh HLA-DR1 (DRA*0101, DRB1*0101) 36 54 21
1aqd 54 21
2seb HLA-DR4 (DRA*0101, DRB1*0401) 36 21
1a6a HLA-DR3 (DRA*0101, DRB1*0301) 54 21
1iea H-2Ek 36 12 12 21
1ieb 12 12 21
1iao H-2Ad
2iad 21
1iak H-2Ak 21
Stabilization centers involving at least one residue from helices are documented.
†Residues of helical origin.
TABLE 5 Stabilization center elements in MHCI-peptide complexes connecting the helices of the peptide binding groove to the
peptide ligand
PDB code MHC I allotype
Amino acids of the bound peptides
Relative position*
Peptide-MHC stabilization centers†
1 helix 2 helix
1 2 3 4 5 6 7 8 9 10 63 66 70 73 77 146 147 155 156
1hhg HLA-A*0201 T L T S C N T S V 2,3
1hhh F L P S D F F P S V 2,3
1hhi G I L G F V F T L 2
1hhj I L K E P V H G V 2
1hhk L L F G Y P V Y V 2
2clr M L L S V P L L L G 2
1b0g A L W G F F P V L 2,3,4 3
1agd HLA-B*0801 G G K K K Y K L
1aln HLA-B*3501 V P L R P M T Y
1a9e L P P L D I T P Y
1alo HLA-B*5301 K P I V Q Y D N F 8 5
1alm T P Y D I N Q M L 2 3 8
1hoc H-2Db A S N E N M E T M 8 8 8
1ce6 F A P G N Y P A L 8 5,6
1bz9 F A P G V F P Y M 8
2vaa H-2Kb R G Y V Y Q G L
2vab F A P G N Y P A L
1vac S I I N F E K L 2,3
1vad S R D H S R T P M 2 4
1ld9 H-2Ld Y P N V N I H N F 5 5
1ddh H-2Dd R G P G R A F V T I 7 9 9
*Amino acids of the bound peptide. Bold indicates residues that form stabilization centers with the MHC protein.
†Position of SC elements in the 1 and 2 helices and the relative position of the corresponding residues in the bound peptide (bold) are given as numbers.
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TABLE 6 Stabilization center elements in MHCII-peptide complexes connecting the helices of the peptide binding groove to the peptide ligand
PDB code MHC II allotype
Amino acids of the bound peptides
Relative position*
Peptide-MHC stabilization centers#
1 helix 1 helix
4 3 2 1 1 2 3 4 5 6 7 8 9 10 11 52§ 53§ 65 68 69 72 60 71 74 82 85
1dlh HLA-DR1 (DRA*0101, DRB1*0101) P K Y V K Q N T L K L A T 8 9 9 1
1aqd G S D W R F L R G Y H Q Y A 9
2seb HLA-DR4 (DRA*0101, DRB1*0401) Q Y M R A D Q A A G G L (1) 9
1bx2 HLA-DR2 (DRA*0101, DRB1*1502) E N P V V H F F A N I V T P (3),(2) (2)
1a6a HLA-DR3 (DRA*0101, DRB1*0301) P V S K M R M A T P L L M Q A (2) (2) 8 9 5 5
1iea H-2Ek G K K V I T A F N E G L K (2) (1) 1 (1)
1ieb R D R M V N H F I A E F K 1 (1)
1iao H-2Ad R G I S Q A V H A A H A E I 8 9
2iad G H A T Q G V T A A S S H E 1
1iak H-2Ak S T D Y G I L Q I N S R W (1) 7 8 9
*Amino acids of the bound peptide. Bold indicates residues that form stabilization centers with the MHC protein.
#Position of SC elements in the 1 and 1 helices and the relative position of the corresponding residues in the bound peptide are given as numbers.
§N terminal cap of the helix.
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themselves we often found them as supporting residues in
the flanking tetrapeptides of the SC element. Some SC
elements are located in the N-terminal flanking region of the
peptide, which extends the binding groove of the protein. It
is noteworthy that N-terminal elongation of peptide deter-
minants beyond the first primary anchor was recently shown
to improve peptide binding to MHC class II molecules
(Bartnes et al., 1999).
The stability of MHC class II heterodimers as well as
superdimers (Schafer et al., 1998) also found in the cell
surface depends on the bound peptide (Germain and Mar-
gulies, 1993; Germain and Rinker, 1993), although appar-
ently to a lesser extent than for class I molecules (Stern and
Wiley, 1992; Reich et al., 1997). Peptides facilitate the
assembly of the two chains in the endoplasmic reticulum,
and determine their longevity in endosomal compartments
and at the cell surface (Germain, 1995). Hydrogen bonds
between conserved amino acids of MHC class II molecules
and the backbone of the peptide make profound contribu-
tions to stabilization of the complex and to increasing en-
zyme susceptibility (Ceman et al., 1998). Stability of MHC
class II-peptide complexes can be so delicately balanced
that disruption of a single solvent-exposed hydrogen bond
(such as substitution of histidine by asparagine at position
81) can lead to defects in complex assembly and speed up
dissociation of the peptide, which is the triggering step in
protein degradation (McFarland et al., 1999). It is notewor-
thy, that the conserved 81 histidine is located between
residue 80 which forms an SC with another protein residue
and 82 which forms an SC with peptide residues in many
MHC class II proteins (see Tables 3 and 6). His 81 was
found to be a supporting residue in all these cases. However,
not all residues play the same role in stabilization, since, for
example, loss of intramolecular interactions such as the salt
bridge between 76 arginine and 57 aspartic acid in the
resistant allotypes against insulin-dependent diabetes mel-
litus, can initiate local rearrangement of the peptide binding
groove without altering global tertiary structure (Sato et al.,
1999).
Empty MHC class II molecules were shown to have two
peptide-free isomers; the active, peptide-receptive form is
unstable and rapidly converts to an inactive one (Rabinow-
itz et al., 1998), which aggregates, becomes sensitive to
proteases, and is degraded in endosomes (Germain and
Rinker 1993). Under in vivo conditions, the folding, intra-
cellular transport and continuous groove occupancy of
MHC class II molecules is directed by the invariant chain
(Ii), which acts as a chaperone for newly synthesized 
dimers, targets them to the endosomal compartments, and
retards them from the cell surface in an inactive state.
Removal of Ii is mediated by multistep proteolytic degra-
dation, which results in the generation of class II associated
invariant chain peptide (CLIP), peptides covering the 81–
104 sequence of Ii, which bind to various MHC class II
molecules and occupy the peptide binding groove until it is
exchanged by a self- or an antigenic peptide. This process
takes place in acidic MHC-rich compartments and only
rarely on the cell surface, and it is catalyzed by the MHC-
like HLA-DM/H-2M chaperone molecule (Koopmann et
al., 1997). A large number of peptidic SC-elements were
found in the CLIP peptide complexed with the HLA-DR3
molecule that is expressed on the surface of HLA-DM
deficient cells (Table 6; Ghosh et al., 1995).
In their immature differentiation state, dendritic cells, the
most potent of the professional antigen presenting cells,
express a large fraction of empty MHC class II molecules.
These are in a peptide-receptive state, bind exogenous pro-
tein fragments, and present them for T cells (Santambrogio
et al., 1999). Immature dendritic cells also express MHC-Ii
complexes, which traffic to the cell surface before internal-
ization into the endosomal peptide-loading compartment.
Peptide uptake by these unusual MHC class II molecules is
assisted by functional HLA-DM molecules expressed on the
cell surface (Arndt et al., 2000). Thus they acquire a novel
extracellular receptor function, which broadens the spec-
trum of peptides captured and saved by MHC class II
molecules of dendritic cells, which in turn play a pivotal
role in priming immune responses.
Stabilization centers of MHC class
I-peptide complexes
In five out of the 21 MHC class I-peptide complexes, no
peptide-protein SC could be identified. In these five cases,
one of the helices was not stabilized by any SC. Binding
experiments with various peptides indicated that terminal
residues of the peptide, which interacted not only with
residues of the helices but also with conserved amino acids,
at the closed ends of the MHC class I groove, contributed
significantly to the binding energy (Madden, 1995). These
promising candidates could not be recognized as SC ele-
ments because of the special definition of SC that requires
flanking segments to occur on both sides of an SC element
(Doszta´nyi et al., 1997). Based on our earlier study of a
large number of proteins, SC elements made 1.77 times
more long range interatomic interactions than did those
residues involved in long range interactions that were not
SC elements (Doszta´nyi et al., 1997). Therefore, the ex-
tremely large number of inter-atomic interactions identifies
SC element-like residues. In all 31 complexes studied, all
323 residues of the bound peptides had interactions with
MHC-derived atoms; therefore, all of them were involved in
long range interactions. Fifty-two were SC elements, and 42
were terminal residues of the bound peptides. A comparison
of the numbers of long-range atomic contacts shows that the
average number is larger for residues, at the termini of
bound peptides than for the same type of SC residues and
almost twice that of the rest of the residues (Table 7). This
suggests that although the terminal residues in question can
not be recognized as SC elements, their interactions with the
2310 Simon et al.
Biophysical Journal 79(5) 2305–2313
MHC class I protein are so pronounced that in fact they play
the same role as do SC elements in structure stabilization, so
they could be called quasi-SC elements.
Differences in serology and thermal lability indicated that
MHC class I molecules lacking peptide have a structure
significantly different from those complexed with peptide
ligands. Empty MHC class I molecules possess partially
folded 1 and 2 domains and many of their physical
properties are typical of molten globules (Bouvier et al.,
1998). A small proportion (3–5%) of native -chains was
detected on the surface of T cells (Edidin et al., 1997), but
empty MHC class I molecules can be transported to the cell
surface only at sub-physiological temperatures (Ljunggren
et al., 1990). These results demonstrate that the MHC class
I ligand binding site is inherently unstable in the absence of
peptide. To select peptide under in vivo conditions, the
highly polymorphic MHC class I -chains interact with
2-microglobulin. Analyzing SC elements in the peptide
binding domains we found that the polymorphic 76 resi-
due and the tryptophan at position 60 in 2-microglobulin
form an SC in almost all studied MHC-peptide complexes
except one of the HLA-A2 complexes (Table 1, no.2).
Intracellular loading of MHC class I molecules is also
assisted by chaperones, which maintain the fragile peptide-
binding sites in a peptide-receptive conformation, and retain
the class I molecules in the endoplasmic reticulum until
peptide binding occurs. MHC class I molecules, transported
to the cell surface, retain their folded peptide binding site
and are stable for hours or even days (Micheletti et al.,
1999). However, some MHC class I molecules, such as the
murine H-2Ld protein, exhibit weak interaction with pep-
tides and with 2-microglobulin (Balendiran et al., 1997).
As a consequence, their peptide loading within the cell is
insufficient and results in low level cell surface expression;
the Ld molecules have an unusually short half-life and are
able to exchange their peptides for exogenous ligands (Han-
sen et al., 2000). In accord with these data, our analysis
failed to detect SCs in the -helices of the H-2Ld molecule
(Table 3), but SC elements were detected in the peptide
ligand (Table 5). Thus, MHC class I molecules, which
display quantitative differences in their interactions with
peptides and other molecules involved in intracellular pep-
tide loading, may also acquire novel functions that provide
alternative pathways for antigen presentation (Jondal et al.,
1996; Khare et al., 1996; Hansen et al., 2000).
Our survey suggests that SCs and quasi-SCs composed of
residues derived from both the protein and the complexed
peptide can be vital for ensuring the compact structure of
MHC proteins by fixing their -helices. These highly or-
dered structures play a pivotal role in stabilizing the molec-
ular surface which contacts the T cell antigen receptor and
also support a stable MHC conformation resistant to pro-
teolytic attack (Willcox et al., 1999).
CONCLUSION
We suggest a new view of function-related regulation of the
stability of MHC proteins by SCs, which were analyzed in
31 MHC-peptide complexes of known three-dimensional
structure. The primary biological function of MHC proteins
is to bind intracellular peptides, generated by limited pro-
teolysis and loaded onto nascent or recycling MHC class I
or class II proteins inside the cell, to transport them to the
cell surface and hold them there until they are recognized by
T cells. To accomplish this job MHC molecules must ac-
quire a stable conformation. Although MHC molecules can
bind a wide array of peptides, almost every one of them
carries only one ligand to the cell surface in its lifetime;
only a few molecules lose and exchange their ligands at the
cell surface or after their recycling to endosomes. The
peptide binds to the protein noncovalently; without the
dissociable peptide ligand, the MHC molecule loses its
stable structure very rapidly and becomes sensitive to pro-
teolytic degradation.
We suggest in this paper that regulation of protein sta-
bility is based on the formation of SCs composed of resi-
dues from both the peptide binding groove of the MHC
protein and the small dissociable ligand. These SCs stabilize
the helices bordering the peptide binding groove and the
remainder of the MHC protein. Thus, these interactions may
also be essential for capturing the peptide and so generating
a novel molecular surface, recognizable by the T cell recep-
TABLE 7 Average number of stabilization centers and long
range atomic contacts in globular proteins, in MHC molecules
and of peptide termini in MHC I complexes
AA
LRI
TR
SC
GPDB MHC MHC GPDB
A 13 30 53 36 27
C 22 6 — — 32
D 18 34 — — 31
E 17 25 — — 36
F 40 54 103 16 62
G 12 16 37 13 24
H 26 37 — 40 49
I 26 25 74 72 45
K 19 54 60 26 39
L 23 53 77 78 41
M 23 43 79 40 41
N 20 29 — 46 34
P 18 32 — 49 30
Q 21 52 — 56 40
R 32 58 100 90 50
S 16 26 56 35 32
T 18 28 69 38 33
V 22 24 66 43 38
W 53 73 — 93 81
Y 40 47 100 72 58
AA, one letter code of amino acids; LRI, long-range interactions; TR,
terminal residue; SC, stabilization center; GPDB, globular protein data-
base.
, lack of given residue in the respective positions in the database.
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tor (Willcox et al., 1999). Because these SCs are missing in
the ligand-free protein, the empty MHC molecules are frag-
ile. The lifetime of MHC class I-peptide complexes at the
cell surface determines the efficiency of cytotoxic T lym-
phocytes, which play a pivotal role in virus- and tumor-
specific responses. Stable MHC class II-peptide complexes
trigger helper T cell responses, which regulate immune
responses against foreign and self-antigens and may cause
autoimmune diseases. Ligand-free MHC molecules are im-
munologically incompetent and have a short half life, but
they may acquire novel biological functions or become a
source of amino acids for de novo protein synthesis.
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